MARKSANS vs INDOCO: Stock Comparison
Head-to-head financial and trading comparison between Marksans Pharma Limited (MARKSANS) and Indoco Remedies Limited (INDOCO) in the Cross-Sector Peers sector.
MARKSANS
NSE: MARKSANSINDOCO
NSE: INDOCOKey Metrics Comparison Table
| Metric | MARKSANS | INDOCO | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹309.10 | ₹230.70 | — |
| 1-Year Price Return | +74.73% | +6.99% | MARKSANS (67.74% higher) |
| 52-Week High | ₹347.60 | ₹273.77 | — |
| 52-Week Low | ₹176.77 | ₹193.13 | — |
| 30-Day Annualized Volatility | 42.37% | 70.87% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 2,394,723 | 1,941,708 | MARKSANS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MARKSANS and INDOCO, which stock gave better returns over the last year?
MARKSANS has outperformed INDOCO over the past 12 months with a gain of 74.73% compared to 6.99%.
Which stock is less volatile: MARKSANS or INDOCO?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to INDOCO (70.87%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MARKSANS vs INDOCO?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MARKSANS and INDOCO direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.